XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.4
Unaudited Condensed Consolidated Statements of Changes in Shareholders' Equity (Deficit) - USD ($)
Ordinary Shares
Class A
Ordinary Shares
Class B
Additional Paid-in Capital
Retained Earnings
Total
Balance at Sep. 30, 2024 $ 46 $ 144 $ 2,614,400 $ 250,396 $ 2,864,986
Balance (in Shares) at Sep. 30, 2024 458,000 1,437,500 [1]      
Accretion of carrying value to redemption value (1,393,904) (1,393,904)
Net (loss) income 542,018 542,018
Balance at Dec. 31, 2024 $ 46 $ 144 1,220,496 792,414 2,013,100
Balance (in Shares) at Dec. 31, 2024 458,000 1,437,500 [1]      
Balance at Sep. 30, 2025 $ 46 $ 144 (625,463) (625,273)
Balance (in Shares) at Sep. 30, 2025 458,000 1,437,500 [1]      
Subsequent measurement of ordinary shares subject to redemption (interest earned on trust account) (299,353) (299,353)
Accretion of carrying value to redemption value
Term extension fee       (450,000) (450,000)
Net (loss) income (118,289) (118,289)
Balance at Dec. 31, 2025 $ 46 $ 144 $ (1,493,105) $ (1,492,915)
Balance (in Shares) at Dec. 31, 2025 458,000 1,437,500 [1]      
[1] This number retroactively restated to include an aggregate of 187,500 Class B ordinary shares as a result of the underwriter’s full exercise of their over-allotment option on July 8, 2025. No Founder Shares are currently subject to forfeiture (see Note 5).